Review: Bioactive marine drugs and marine biomaterials for brain diseases

Marine Drugs

Volumn 12, Issue 5, 2014, Pages 2539-2589

  Grosso, Clara ^a   Valentão, Patrícia ^a   Ferreres, Federico ^b   Andrade, Paula B ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Aragonite; A peptide; Conotoxins; Cyclooxygenases; Neurodegeneration; Neuroinflammation; Protein kinases; Receptors; Tau hyperphosphorylation; Voltage dependent ion channels

Indexed keywords

ACETYLCHOLINE RECEPTOR MODULATOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALKALOID DERIVATIVE; ANTIINFLAMMATORY AGENT; BETA SECRETASE INHIBITOR; BIOMATERIAL; BROMOPYRROLE ALKALOID; CALCIUM CHANNEL MODULATOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG; DYRK1A INHIBITOR; GLUTAMIC ACID RECEPTOR MODULATOR; GLYCINE RECEPTOR MODULATOR; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; HISTAMINERGIC RECEPTOR AFFECTING AGENT; MARINE DRUG; NEUROPROTECTIVE AGENT; NEUROTOXIN; NEUROTROPHIN; NEUROTROPHIN ENHANCER AGENT; POTASSIUM CHANNEL MODULATOR; PROTEIN INHIBITOR; PROTEIN KINASE INHIBITOR; SEROTONIN RECEPTOR MODULATOR; SODIUM CHANNEL MODULATOR; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; UNINDEXED DRUG; BIOLOGICAL PRODUCT;

BIOTECHNOLOGY; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; DRUG TARGETING; HUMAN; INVERTEBRATE; MARINE INVERTEBRATE; MARINE SPECIES; MEDICAL RESEARCH; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPHARMACOLOGY; NEUROSCIENCE; NONHUMAN; REVIEW; TISSUE ENGINEERING; ANIMAL; AQUATIC SPECIES; BRAIN DISEASES; CARBOHYDRATE ANALYSIS; CHEMISTRY; DRUG EFFECTS; MOLECULAR GENETICS; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; TRENDS;

ANIMALS; AQUATIC ORGANISMS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL PRODUCTS; BRAIN DISEASES; CARBOHYDRATE SEQUENCE; HUMANS; INVERTEBRATES; MOLECULAR SEQUENCE DATA; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; NEUROSCIENCES; TISSUE ENGINEERING;

EID: 84901419567     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12052539     Document Type: Review

References (262)

1. Kanwar, J.R.; Sriramoju, B.; Kanwar, R.K. Neurological disorders and therapeutics targeted to surmount the blood-brain barrier. Int. J. Nanomedicine 2012, 7, 3259-3278.
2. Glaser, K.B.; Mayer, A.M.S. A renaissance in marine pharmacology: From preclinical curiosity to clinical reality. Biochem. Pharmacol. 2009, 78, 440-448.
3. Mayer, A.M.S.; Rodríguez, A.D.; Berlinck, R.G.S.; Fusetani, N. Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 2011, 153, 191-222.
4. Essack, M.; Bajic, V.B.; Archer, J.A.C. Conotoxins that confer therapeutic possibilities. Mar. Drugs 2012, 10, 1244-1265.
5. Mortari, M.R.; Cunha, A.O.S.; Ferreira, L.B.; dos Santos, W.F. Neurotoxins from invertebrates as anticonvulsants: From basic research to therapeutic application. Pharmacol. Ther. 2007, 114, 171-183. (Pubitemid 46561533)
6. Mayer, A.M.S.; Glaser, K.B.; Cuevas, C.; Jacobs, R.S.; Kem, W.; Little, R.D.; McIntosh, J.M.; Newman, D.J.; Potts, B.C.; Shuster, D.E. The odyssey of marine pharmaceuticals: A current pipeline perspective. Trends Pharmacol. Sci. 2010, 31, 255-265.
7. Kem, W. Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist. Invertebr. Neurosci. 1997, 3, 251-259. (Pubitemid 28433024)
8. Livett, B.G.; Gayler, K.R.; Khalil, Z. Drugs from the Sea: Conopeptides as potential therapeutics. Curr. Med. Chem. 2004, 11, 1715-1723. (Pubitemid 38821340)
9. Layer, R.T.; McIntosh, J.M. Conotoxins: Therapeutic potential and application. Mar. Drugs 2006, 4, 119-142. (Pubitemid 43763909)
10. Twede, V.D.; Miljanich, G.; Olivera, B.M.; Bulaj, G. Neuroprotective and cardioprotective conopeptides: An emerging class of drug leads. Curr. Opin. Drug Discov. Devel. 2009, 12, 231-239.
11. Sakai, R.; Swanson, G.T. Recent progress in neuroactive marine natural products. Nat. Prod. Rep. 2014, 31, 273-309.
12. Arias, H.R. Marine toxins targeting ion channels. Mar. Drugs 2006, 4, 37-69.
13. Al-Sabi, A.; McArthur, J.; Ostroumov, V.; French, R.J. Marine toxins that target voltage-gated sodium channels. Mar. Drugs 2006, 4, 157-192. (Pubitemid 43763911)
14. Kochanowska-Karamyan, A.; Hamann, M.T. Marine indole alkaloids: Potential new drug leads for the control of depression and anxiety. Chem. Rev. 2010, 110, 4489-4497.
15. Bharate, S.B.; Sawant, S.D.; Singh, P.P.; Vishwakarma, R.A. Kinase inhibitors of marine origin. Chem. Rev. 2013, 113, 6761-6815.
16. Skropeta, D.; Pastro, N.; Zivanovic, A. Kinase inhibitors from marine sponges. Mar. Drugs 2001, 9, 2131-2154.
17. Nakao, Y.; Fusetani, N. Enzyme inhibitors from marine invertebrates. J. Nat. Prod. 2007, 70, 689-710. (Pubitemid 46797884)
18. Senthilkumar, K.; Kim, S.-K. Marine invertebrate natural products for anti-inflammatory and chronic diseases. Evid. Based Complement. Alternat. Med. 2013, 2013, 572859:1-572859:10.
19. Martínez, A. Marine-derived drugs in neurology. Curr. Opin. Invest. Drugs 2007, 8, 525-530.
20. Schmidt, C.E.; Leach, J.B. Neural tissue engineering: strategies for repair and regeneration. Annu. Rev. Biomed. Eng. 2003, 5, 293-347. (Pubitemid 40125315)
21. Kettenmann, H.; Verkhratsky, A. Neuroglia, der lebende Nervenkitt. Fortschr. Neurol. Psychiatr. 2011, 79, 588-597.
22. Giugliano, M. Calcium waves in astrocyte networks: Theory and experiments. Front. Neurosci. 2009, 3, 160-161.
23. Allen, N.J.; Barres, B.A. Neuroscience: Glia - More than just brain glue. Nature 2009, 457, 675-677.
24. Dowding, A.J.; Scholes, J. Lymphocytes and macrophages outnumber oligodendroglia in normal fish spinal cord. Proc. Natl. Acad. Sci. USA 1993, 90, 10183-10187. (Pubitemid 23328276)
25. Horner, P.J.; Gage, F.H. Regenerating the damaged central nervous system. Nature 2000, 407, 963-970.
26. Shoichet, M.S.; Tate, C.C.; Baumann, M.D.; LaPlaca, M.C. Indwelling Neural Implants: Strategies for Contending with the in Vivo Environment; Reichert, W.M., Ed.; CRC Press: Boca Raton, FL, USA, 2008.
27. Cullen, D.K.; Stabenfeldt, S.E.; Simon, C.M.; Tate, C.C.; LaPlaca, M.C. In vitro neural injury model for optimization of tissue-engineered constructs. J. Neurosci. Res. 2007, 85, 3642-3651. (Pubitemid 350228709)
28. Baranes, D.; Cove, J.; Blinder, P.; Shany, B.; Peretz, H.; Vago, R. Interconnected network of ganglion-like neural cell spheres formed on hydrozoan skeleton. Tissue Eng. 2007, 13, 473-482. (Pubitemid 46579874)
29. Yiu, G.; He, Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7, 617-627. (Pubitemid 44106744)
30. Avellino, A.M.; Hart, D.; Dailey, A.T.; Mackinnon, M.; Ellegala, D.; Kliot, M. Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons. Exp. Neurol. 1995, 136, 183-198.
31. Kuhlmann, T.; Wendling, U.; Nolte, C.; Zipp, F.; Maruschak, B.; Stadelmann, C.; Siebert, H.; Brück, W. Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins. J. Neurosci. Res. 2002, 67, 185-190.
32. Huebner, E.; Strittmatter, S. Cell Biology of the Axon; Koenig, E., Ed.; Springer: Berlin Heidelberg, Germany, 2009; Volume 48, pp. 305-360.
33. Plunet, W.; Kwon, B.K.; Tetzlaff, W. Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy. J. Neurosci. Res. 2002, 68, 1-6. (Pubitemid 34274991)
34. Di Giovanni, S. Regeneration following spinal cord injury, from experimental models to humans: where are we? Expert Opin. Ther. Targets 2006, 10, 363-376. (Pubitemid 43949951)
35. Pfister, B.J.; Gordon, T.; Loverde, J.R.; Kochar, A.S.; Mackinnon, S.E.; Cullen, D.K. Biomedical engineering strategies for peripheral nerve repair: Surgical applications, state of the art, and future challenges. Crit. Rev. Biomed. Eng. 2011, 39, 81-124.
36. Scholz, T.; Krichevsky, A.; Sumarto, A.; Jaffurs, D.; Wirth, G.A.; Paydar, K.; Evans, G.R.D. Peripheral nerve injuries: An international survey of current treatments and future perspectives. J. Reconstr. Microsurg. 2009, 25, 339-344.
37. Moore, A.; Kasukurthi, R.; Magill, C.; Farhadi, H.F.; Borschel, G.; Mackinnon, S. Limitations of conduits in peripheral nerve repairs. Hand 2009, 4, 180-186.
38. Suna, H.; Arai, M.; Tsubotani, Y.; Hayashi, A.; Setiawan, A.; Kobayashi, M. Dysideamine, a new sesquiterpene aminoquinone, protects hippocampal neuronal cells against iodoacetic acid-induced cell death. Bioorg. Med. Chem. 2009, 17, 3968-3972.
39. Aoki, S.; Wei, H.; Matsui, K.; Rachmat, R.; Kobayashi, M. Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis. Bioorg. Med. Chem. 2003, 1969-1973. (Pubitemid 36379013)
40. Aoki, S.; Matsui, K.; Tanaka, K.; Satari, R.; Kobayashi, M. Lembehyne A, a novel neuritogenic polyacetylene, from a marine sponge of Haliclona sp. Tetrahedron 2000, 56, 9945-9948.
41. Aoki, S.; Matsui, K.; Takata, T.; Hong, W.; Kobayashi, M. Lembehyne A, a spongean polyacetylene, induces neuronal differentiation in neuroblastoma cell. Biochem. Biophys. Res. Commun. 2001, 289, 558-563. (Pubitemid 33141091)
42. Aoki, S.; Matsui, K.; Wei, H.; Murakami, N.; Kobayashi, M. Structure-activity of neuritogenic spongean acetylene alcohols, lembehynes. Tetrahedron 2002, 58, 5417-5422. (Pubitemid 34671221)
43. Han, C.; Qi, J.; Ojika, M. Structure-activity relationships of novel neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. Bioorg. Med. Chem. 2006, 14, 4458-4465. (Pubitemid 43728656)
44. Palyanova, N.V., Pankova, T.M.; Starostina, M.V.; Kicha, A.A.; Ivanchina, N.V.; Stonik, V.A. Neuritogenic and neuroprotective effects of polar steroids from the far east starfishes Patiria pectinifera and Distolasterias nipon. Mar. Drugs 2013, 11, 1440-1445.
45. Qi, J.; Han, C.; Sasayama, Y.; Nakahara, H.; Shibata, T.; Uchida, K.; Ojika, M. Granulatoside A, a starfish steroid glycoside, enhances PC12 cell neuritogenesis induced by nerve growth factor through an activation of MAP kinase. Chem. Med. Chem. 2006, 1, 1351-1354.
46. Inagaki, M.; Miyamoto, T.; Isobe, R.; Higuchi, R. Biologically active glycosides from Asteroidea, 43. Isolation and structure of a new neuritogenic-active ganglioside molecular species from the starfish Linckia laevigata. Chem. Pharm. Bull. 2005, 53, 1551-1554. (Pubitemid 41744481)
47. Qi, J.; Ojika, M.; Sakagami, Y. Linckosides A and B, two new neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. Bioorg. Med. Chem. 2002, 10, 1961-1966. (Pubitemid 34286389)
48. Higuchi, R.; Inoue, S.; Inagaki, K.; Sakai, M.; Miyamoto, T.; Komori, T.; Inagaki, M.; Isobe, R. Biologically active glycosides from Asteroidea, 42. Isolation and structure of a new biologically active ganglioside molecular species from the starfish Asterina pectinifera. Chem. Pharm. Bull. 2006, 54, 287-291.
49. Kisa, F.; Yamada, K.; Miyamoto, T.; Inagaki, M.; Higuchi, R. Constituents of Holothuroidea, 18. Isolation and structure of biologically active disialo- and trisialo-gangliosides from the sea cucumber Cucumaria echinata. Chem. Pharm. Bull. 2006, 54, 1293-1298. (Pubitemid 44351524)
50. Kisa, F.; Yamada, K.; Miyamoto, T.; Inagaki, M.; Higuchi, R. Constituents of Holothuroidea, 17. Isolation and structure of biologically active monosialo-gangliosides from the sea cucumber Cucumaria echinata. Chem. Pharm. Bull. 2006, 54, 982-987.
51. Buée, L.; Bussière, T.; Buée-Scherrer, V.; Delacourte, A.; Hof, P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev. 2000, 33, 95-130.
52. Kar, S.; Slowikowski, S.P.M.; Westaway, D.; Mount, H.T.J. Interactions between β-amyloid and central cholinergic neurons: Implications for Alzheimer's disease. J. Psychiatry Neurosci. 2004, 29, 427-441. (Pubitemid 40075714)
53. Beedessee, G.; Ramanjooloo, A.; Surnam-Boodhun, R.; van Soest, R.W.M.; Marie, D.E.P. Acetylcholinesterase-inhibitory activities of the extracts from sponges collected in Mauritius waters. Chem. Biodivers. 2013, 10, 442-451.
54. Dai, X.-L.; Sun, Y.-X.; Jiang, Z.-F. Attenuated cytotoxicity but enhanced βfibril of a mutant amyloid β-peptide with a methionine to cysteine substitution. FEBS Lett. 2007, 581, 1269-1274. (Pubitemid 46452599)
55. Kubo, T.; Nishimura, S.; Kumagae, Y.; Kaneko, I. In vivo conversion of racemized β-amyloid ([D-Ser26]Aβ1-40) to truncated and toxic fragments ([D-Ser26]Aβ25-35/40) and fragment presence in the brains of Alzheimer's patients. J. Neurosci. Res. 2002, 70, 474-483. (Pubitemid 35222384)
56. Peña, F.; Ordaz, B.; Balleza-Tapia, H.; Bernal-Pedraza, R.; Márquez-Ramos, A.; Carmona-Aparicio, L.; Giordano, M. Beta-amyloid protein (25-35) disrupts hippocampal network activity: Role of Fyn-kinase. Hippocampus 2010, 20, 78-96.
57. Wang, J.; Gao, Q.-S.; Wang, Y.; Lafyatis, R.; Stamm, S.; Andreadis, A. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J. Neurochem. 2004, 88, 1078-1090. (Pubitemid 38280676)
58. Hanger, D.P.; Byers, H.L.; Wray, S.; Leung, K.-Y.; Saxton, M.J.; Seereeram, A.; Reynolds, C.H.; Ward, M.A.; Anderton, B.H. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 2007, 282, 23645-23654. (Pubitemid 47311907)
59. Ryoo, S.-R.; Jeong, H.K.; Radnaabazar, C.; Yoo, J.-J.; Cho, H.-J.; Lee, H.-W.; Kim, I.-S.; Cheon, Y.-H.; Ahn, Y.S.; Chung, S.-H.; Song, W.-J. DYRK1A-mediated hyperphosphorylation of tau: A functional link between Down syndrome and Alzheimer disease. J. Biol. Chem. 2007, 282, 34850-34857. (Pubitemid 350232475)
60. Schober, A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004, 318, 215-224. (Pubitemid 39366054)
61. Perez, D.I.; Gil, C.; Martinez, A. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med. Res. Rev. 2011, 31, 924-954.
62. Wang, Y.; Shi, M.; Chung, K.A.; Zabetian, C.P.; Leverenz, J.B.; Berg, D.; Srulijes, K.; Trojanowski, J.Q.; Lee, V.M.; Siderowf, A.D.; et al. Phosphorylated α-synuclein in Parkinson's disease. Sci. Transl. Med. 2012, 4, 121ra20.
63. Turk,T.; Avguštin, J.A.; Batista, U.; Strugar, G.; Kosmina, R.; Čivović, S.; Janussen, D.; Kauferstein, S.; Mebs, D.; Sepčić, K. Biological activities of ethanolic extracts from deep-sea antarctic marine sponges. Mar. Drugs 2013, 11, 1126-1139.
64. Langjae, R.; Bussarawit, S.; Yuenyongsawad, S.; Ingkaninan, K.; Plubrukarn, A. Acetylcholinesterase-inhibiting steroidal alkaloid from the sponge Corticium sp. Steroids 2007, 72, 682-685. (Pubitemid 47161089)
65. Nukoolkarn, V.S.; Saen-oon, S.; Rungrotmongkol, T.; Hannongbua, S.; Ingkaninan, K.; Suwanborirux, K. Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp. Bioorg. Med. Chem. 2008, 16, 6560-6567.
66. Ata, A.; Ackerman, J.; Bayoud, A.; Radhika, P. Bioactive Chemical constituents of Cladiella species. Helv. Chim. Acta. 2004, 87, 592-597. (Pubitemid 38543998)
67. Kigoshi, H.; Kanematsu, K.; Yokota, K.; Uemura, D. Turbotoxins A and B, novel diiodotyramine derivatives from the Japanese gastropod Turbo marmorata. Tetrahedron 2000, 56, 9063-9070.
68. Williams, P; Sorribas, A.; Liang, Z. New methods to explore marine resources for Alzheimer's therapeutics. Curr. Alzheimer Res. 2000, 7, 210-213.
69. Dai, J.; Sorribas, A.; Yoshida, W.Y.; Kelly, M.; Williams, P.G. Xestosaprols from the Indonesian marine sponge Xestospongia sp. J. Nat. Prod. 2010, 73, 1188-1191.
70. Dai, J.; Sorribas, A.; Yoshida, W.Y.; Kelly, M.; Williams, P.G. Topsentinols, 24-isopropyl steroids from the marine sponge Topsentia sp. J. Nat. Prod. 2010, 73, 1597-1600.
71. Dai. J.; Jiménez, J.I.; Kelly, M.; Williams, P.G. Dictazoles: Potential vinyl cyclobutane biosynthetic precursors to the dictazolines. J. Org. Chem. 2010, 75, 2399-2402.
72. Millán-Aguiñaga, N.; Soria-Mercado, I.E.; Williams, P. Xestosaprol D and E from the Indonesian marine sponge Xestospongia sp. Tetrahedron Lett. 2000, 51, 751-753.
73. Zhang, H.; Conte, M.M.; Huang, X.C.; Khalil, Z.; Capon, R.J. A search for BACE inhibitors reveals new biosynthetically related pyrrolidones, furanones and pyrroles from a southern Australian marine sponge, Ianthella sp. Org. Biomol. Chem. 2012, 10, 2656-2663.
74. Zhang, H.; Conte, M.M.; Khalil, Z.; Huang, X.-C.; Capon, R.J. New dictyodendrins as BACE inhibitors from a southern Australian marine sponge, Ianthella sp. RSC Adv. 2012, 2, 4209-4214.
75. Rayasam, G.V.; Tulasi, V.K.; Sodhi, R.; Davis, J.A.; Ray, A. Glycogen synthase kinase 3: More than a namesake. Br. J. Pharmacol. 2009, 156, 885-898.
76. Bidon-Chanal, A.; Fuertes, A.; Alonso, D.; Pérez, D.I.; Martínez, A.; Luque, F.J.; Medina, M. Evidence for a new binding mode to GSK-3: Allosteric regulation by the marine compound palinurin. Eur. J. Med. Chem. 2013, 60, 479-489.
77. Cho, J.-H.; Johnson, G.V.W. Glycogen synthase kinase 3β phosphorylates tau at both primed and unprimed sites: Differential impact on microtubule binding. J. Biol. Chem. 2003, 278, 187-193. (Pubitemid 36043561)
78. Khanfar, M.A.; Asal, B.A.; Mudit, M.; Kaddoumi, A.; El Sayed, K.A. The marine natural-derived inhibitors of glycogen synthase kinase-3β phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling. Bioorg. Med. Chem. 2009, 17, 6032-6039.
79. Hanger, D.P.; Noble, W. Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int. J. Alzheimers Dis. 2011, 2011, 352805:1-352805:11.
80. Hamann, M.; Alonso, D.; Martín-Aparicio, E.; Fuertes, A.; Pérez-Puerto, M.J.; Castro, A.; Morales, S.; Navarro, M.L.; del Monte-Millán, M.; Medina, M.; et al. Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J. Nat. Prod. 2007, 70, 1397-1405.
81. Meijer, L.; Thunnissen, A.M.; White, A.W.; Garnier, M.; Nikolic, M.; Tsai, L.H.; Walter, J.; Cleverley, K.E.; Salinas, P.C.; Wu, Y.Z.; et al. Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent. Chem. Biol. 2000, 7, 51-63.
82. Glatz, D.C.; Rujescu, D.; Tang, Y.; Berendt, F.J.; Hartmann, A.M.; Faltraco, F.; Rosenberg, C.; Hulette, C.; Jellinger, K.; Hampel, H.; et al. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer?s disease. J. Neurochem. 2006, 96, 635-644.
83. Hernández, F.; Pérez, M.; Lucas, J.J.; Mata, A.M.; Bhat, R.; Avila, J. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35: Implications for Alzheimer?s disease. J. Biol. Chem. 2004, 279, 3801-3806.
84. Phiel, C.J.; Wilson, C.A.; Lee, V.M.-Y.; Klein, P.S. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides. Nature 2003, 423, 435-439. (Pubitemid 36626994)
85. Tahtouh, T.; Elkins, J.M.; Filippakopoulos, P.; Soundararajan, M.; Burgy, G.; Durieu, E.; Cochet, C.; Schmid, R.S.; Lo, D.C.; Delhommel, F.; et al. Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. J. Med. Chem. 2012, 55, 9312-9330.
86. Baunbæk, D.; Trinkler, N.; Ferandin, Y.; Lozach, O.; Ploypradith, P.; Rucirawat, S.; Ishibashi, F.; Iwao, M.; Meijer, L. Anticancer alkaloid lamellarins inhibit protein kinases. Mar. Drugs 2008, 6, 514-527.
87. Gompel, M.; Leost, M.; de Kier Joffe, E.B.; Puricelli, L.; Franco, L.H.; Palermo, J.; Meijer, L. Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum. Bioorg. Med. Chem. Lett. 2004, 14, 1703-1707. (Pubitemid 38340670)
88. McCulloch, M.W.B.; Bugni, T.S.; Concepcion, G.P.; Coombs, G.S.; Harper, M.K.; Kaur, S.; Mangalindan, G.C.; Mutizwa, M.M.; Veltri, C.A.; Virshup, D.M.; et al. Carteriosulfonic acids A-C, GSK-3β inhibitors from a Carteriospongia sp. J. Nat. Prod. 2009, 72, 1651-1656.
89. Gordillo, D.; Diaz, I.; Martinez-Gil, A.; Pliego, G.; Huerta, A.; Puerto, M.J.; Aparicio, E.; Navarro, D.; Padilla, M. Gsk-3 Inhibitors Isolated from Marine Organisms. U.S. Patent 20070088080 A1, 19 April 2007.
90. Debdab, M.; Renault, S.; Lozach, O.; Meijer, L.; Paquin, L.; Carreaux, F.; Bazureau, J.-P. Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors. Eur. J. Med. Chem. 2010, 45, 805-810.
91. Eldar-Finkelman, H.; Martinez, A. GSK-3 inhibitors: Preclinical and clinical focus on CNS. Front. Mol. Neurosci. 2011, 4, 32.
92. Ryoo, S.-R.; Cho, H.-J.; Lee, H.-W.; Jeong, H.K.; Radnaabazar, C.; Kim, Y.-S.; Kim, M.-J.; Son, M.-Y.; Seo, H.; Chung, S.-H.; et al. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: Evidence for a functional link between Down syndrome and Alzheimer's disease. J. Neurochem. 2008, 104, 1333-1344.
93. Ryu, Y.S.; Park, S.Y.; Jung, M.-S.; Yoon, S.-H.; Kwen, M.-Y.; Lee, S.-Y.; Choi, S.-H.; Radnaabazar, C.; Kim, M.-K.; Kim, H.; et al. Dyrk1A-mediated phosphorylation of presenilin 1: A functional link between Down syndrome and Alzheimer's disease. J. Neurochem. 2010, 115, 574-584.
94. Sitz, J.H.; Baumgärtel, K.; Hämmerle, B.; Papadopoulos, C.; Hekerman, P.; Tejedor, F.J.; Becker, W.; Lutz, B. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4. Neuroscience 2008, 157, 596-605.
95. Ihara, M.; Tomimoto, H.; Kitayama, H.; Morioka, Y.; Akiguchi, I.; Shibasaki, H.; Noda, M.; Kinoshita, M. Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson?s disease and other synucleinopathies. J. Biol. Chem. 2003, 278, 24095-24102. (Pubitemid 36830243)
96. Kinoshita, A.; Kinoshita, M.; Akiyama, H.; Tomimoto, H.; Akiguchi, I.; Kumar, S.; Noda, M.; Kimura, J. Identification of septins in neurofibrillary tangles in Alzheimer's disease. Am. J. Pathol. 1998, 153, 1551-1560. (Pubitemid 28509912)
97. Jung, M.-S.; Park, J.-H.; Ryu, Y.S.; Choi, S.-H.; Yoon, S.-H.; Kwen, M.-Y.; Oh, J.Y.; Song, W.-J.; Chung, S.-H. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J. Biol. Chem. 2011, 286, 40401-40412.
98. Park, J.-H.; Jung, M.-S.; Kim, Y.-S.; Song, W.-J.; Chung, S.-H. Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α. J. Neurochem. 2012, 122, 1081-1091.
99. Li, G.; Yin, H.; Kuret, J. Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J. Biol. Chem. 2004, 279, 15938-15945. (Pubitemid 38509281)
100. Flajolet, M.; He, G.; Heiman, M.; Lin, A.; Nairn, A.C.; Greengard, P. Regulation of Alzheimer's disease amyloid-β formation by casein kinase I. Proc. Natl. Acad. Sci. USA 2007, 104, 4159-4164. (Pubitemid 47181595)
101. Piedrahita, D.; Hernández, I.; López-Tobón, A.; Fedorov, D.; Obara, B.; Manjunath, B.S.; Boudreau, R.L.; Davidson, B.; LaFerla, F.; Gallego-Gómez, J.C.; et al. Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer's mice. J. Neurochem. 2010, 30, 13966-13976.
102. Kamei, H.; Saito, T.; Ozawa, M.; Fujita, Y.; Asada, A.; Bibb, J.A.; Saido, T.C.; Sorimachi, H.; Hisanaga, S.-I. Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation. J. Biol. Chem. 2007, 282, 1687-1694. (Pubitemid 47076684)
103. Hernandez, P.; Lee, G.; Sjoberg, M.; Maccioni, R.B. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Aβ25-35: Involvement of lipid rafts. J. Alzheimers Dis. 2009, 16, 149-156.
104. Zheng, Y.-L.; Kesavapany, S.; Gravell, M.; Hamilton, R.S.; Schubert, M.; Amin, N.; Albers, W.; Grant, P.; Pant, H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005, 24, 209-220.
105. Town, T.; Zolton, J.; Shaffner, R.; Schnell, B.; Crescentini, R.; Wu, Y.; Zeng, J.; DelleDonne, A.; Obregon, D.; Tan, J.; et al. p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro. J. Neurosci. Res. 2002, 69, 362-372.
106. Soni, R.; Muller, L.; Furet, P.; Schoepfer, J.; Stephan, C.; Zumstein-Mecker, S.; Fretz, H.; Chaudhuri, B. Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product. Biochem. Biophys. Res. Commun. 2000, 275, 877-884.
107. Beebe, S.J. The cAMP-dependent protein kinases and cAMP signal transduction. Semin. Cancer Biol. 1994, 5, 285-294. (Pubitemid 124006799)
108. Dolan, P.J.; Johnson, G.V.W. The role of tau kinases in Alzheimer's disease. Curr. Opin. Drug Discov. Devel. 2010, 13, 595-603.
109. Adams, D.J.; Alewood, P.F.; Craik, D.J.; Drinkwater, R.D.; Lewis, R.J. Conotoxins and their potential pharmaceutical applications. Drug Develop. Res. 1999, 46, 219-234. (Pubitemid 29258920)
110. McDonough, S.; Swartz, K.; Mintz, I.; Boland, L.; Bean, B. Inhibition of calcium channels in rat central and peripheral neurons by ω-conotoxin MVIIC. J. Neurosci. 1996, 16, 2612-2623. (Pubitemid 26124350)
111. Wen, L.; Yang, S.; Qiao, H.; Liu, Z.; Zhou, W.; Zhang, Y.; Huang, P. SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons. Br. J. Pharmacol. 2005, 145, 728-739. (Pubitemid 41076279)
112. Valentino, K.; Newcomb, R.; Gadbois, T.; Singh, T.; Bowersox, S.; Bitner, S.; Justice, A.; Yamashiro, D.; Hoffman, B.B.; Ciaranello, R. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc. Natl. Acad. Sci. USA 1993, 90, 7894-7897. (Pubitemid 23250057)
113. Anderson, P.D.; Bokor, G. Conotoxins: Potential weapons from the sea. J. Bioterror. Biodef. 2012, 3, 1-4.
114. Favreau, P.; Gilles, N.; Lamthanh, H.; Bournaud, R.; Shimahara, T.; Bouet, F.; Laboute, P.; Letourneux, Y.; Ménez, A.; Molgó, J.; et al. A new ω-conotoxin that targets N-type voltage-sensitive calcium channels with unusual specificity. Biochemistry 2001, 40, 14567-14575.
115. McDonough, S.I.; Boland, L.M.; Mintz, I.M.; Bean, B.P. Interactions among toxins that inhibit N-type and P-type calcium channels. J. Gen. Physiol. 2002, 119, 313-328. (Pubitemid 34311170)
116. Nielsen, K.J.; Watson, M.; Adams, D.J.; Hammarström, A.K.; Gage, P.W.; Hill, J.M.; Craik, D.J.; Thomas, L.; Adams, D.; Alewood, P.F.; et al. Solution structure of μ-Conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels. J. Biol. Chem. 2002, 277, 27247-27255.
117. Theile, J.W.; Cummins, T.R. Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front. Pharmacol. 2011, 2, 54.
118. Dray, A. Neuropathic pain: emerging treatments. Br. J. Anaesth. 2008, 101, 48-58. (Pubitemid 351881912)
119. Hains, B.C.; Klein, J.P.; Saab, C.Y.; Craner, M.J.; Black, J.A.; Waxman, S.G. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. 2003, 23, 8881-8892. (Pubitemid 37210901)
120. Carter, A.J. The importance of voltage-dependent sodium channels in cerebral ischaemia. Amino Acids 1998, 14, 159-169. (Pubitemid 28051166)
121. Ragsdale, D.S.; Avoli, M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Rev. 1998, 26, 16-28. (Pubitemid 28179007)
122. Bulaj, G.; DeLaCruz, R.; Azimi-Zonooz, A.; West, P.; Watkins, M.; Yoshikami, D.; Olivera, B.M. δ-Conotoxin structure/function through a cladistic analysis. Biochemistry 2001, 40, 13201-13208.
123. Santana, A.N.C.; Trindade-Filho, E.M.; Cunha, R.B.; Sousa, M.V.; Cavalheiro, E.A.; Carvalho, K.M. Behavioral and electroencephalographic analysis of seizures induced by intrahippocampal injection of granulitoxin, a neurotoxic peptide from the sea anemone Bunodosoma granulifera. Braz. J. Med. Biol. Res. 2001, 34, 797-801. (Pubitemid 33606617)
124. Bruhn, T.; Schaller, C.; Schulze, C.; Sanchez-Rodriguez, J.; Dannmeier, C.; Ravens, U.; Heubach, J.F.; Eckhardt, K.; Schmidtmayer, J.; Schmidt, H.; et al. Isolation and characterisation of five neurotoxic and cardiotoxic polypeptides from the sea anemone Anthopleura elegantissima. Toxicon 2001, 39, 693-702.
125. Santana, A.N.C.; Leite, A.B.; França, M.S.F.; França, L.; Vale, O.C.; Cunha, R.B.; Ricart, C.A.O.; Sousa, M.V.; Carvalho, K.M. Partial sequence and toxic effects of granulitoxin, a neurotoxic peptide from the sea anemone Bunodosoma granulifera. Braz. J. Med. Biol. Res. 1998, 31, 1335-1338.
126. Wulff, H.; Castle, N.A.; Pardo, L.A. Voltage-gated potassium channels as therapeutic targets. Nat. Rev. Drug Discov. 2009, 8, 982-1001.
127. Kauferstein, S.; Huys, I.; Lamthanh, H.; Stöcklin, R.; Sotto, F.; Menez, A.; Tytgat, J.; Mebs, D. A novel conotoxin inhibiting vertebrate voltage-sensitive potassium channels. Toxicon 2003, 42, 43-52.
128. Ferber, M.; Sporning, A.; Jeserich, G.; DeLaCruz, R.; Watkins, M.; Olivera, B.M.; Terlau, H. A novel Conus peptide ligand for K+ channels. J. Biol. Chem. 2003, 278, 2177-2183. (Pubitemid 36801283)
129. Jensen, A.A.; Frølund, B.; Liljefors, T.; Krogsgaard-Larsen, P. Neuronal nicotinic acetylcholine receptors: Structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 2005, 48, 4705-4745.
130. Paterson, D.; Nordberg, A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 2000, 61, 75-111. (Pubitemid 30100404)
131. Gotti, C.; Clementi, F. Neuronal nicotinic receptors: From structure to pathology. Prog. Neurobiol. 2004, 74, 363-396. (Pubitemid 40092737)
132. Tsuneki, H.; You, Y.; Toyooka, N.; Sasaoka, T.; Nemoto, H.; Dani, J.A.; Kimura, I. Marine alkaloids (-)-pictamine and (-)-lepadin B block neuronal nicotinic acetylcholine receptors. Biol. Pharm. Bull. 2005, 28, 611-614. (Pubitemid 40879924)
133. Green, B.T.; Welch, K.D.; Panter, K.E.; Lee, S.T. Plant toxins that affect nicotinic acetylcholine receptors: A review. Chem. Res. Toxicol. 2013, 26, 1129-1138.
134. Loughnan, M.; Nicke, A.; Jones, A.; Schroeder, C.I.; Nevin, S.T.; Adams, D.J.; Alewood, P.F.; Lewis, R.J. Identification of a novel class of nicotinic receptor antagonists: Dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from Conus vexillum. J. Biol. Chem. 2006, 281, 24745-24755. (Pubitemid 44274249)
135. Gotti, C.; Zoli, M.; Clementi, F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 2006, 27, 482-491. (Pubitemid 44251225)
136. Kem, W.; Soti, F.; Wildeboer, K.; Le Francois, S.; MacDougall, K.; Wei, D.-Q.; Chou, K.-C.; Arias, H. The nemertine toxin anabaseine and its derivative DMXBA (GTS-21): Chemical and pharmacological properties. Mar. Drugs 2006, 4, 255-273. (Pubitemid 43763915)
137. Nicke, A.; Loughnan, M.L.; Millard, E.L.; Alewood, P.F.; Adams, D.J.; Daly, N.L.; Craik, D.J.; Lewis, R.J. Isolation, structure, and activity of GID, a novel α4/7-conotoxin with an extended N-terminal sequence. J. Biol. Chem. 2003, 278, 3137-3144. (Pubitemid 36801224)
138. Ellison, M.; McIntosh, J.M.; Olivera, B.M. α-Conotoxins ImI and ImII: Similar α7 nicotinic receptor antagonists act at different sites. J. Biol. Chem. 2003, 278, 757-764.
139. Peng, C.; Chen, W.; Han, Y.; Sanders, T.; Chew, G.; Liu, J.; Hawrot, E.; Chi, C.; Wang, C. Characterization of a novel α4/4-conotoxin, Qc1.2, from vermivorous Conus quercinus. Biochim. Biophys. Acta 2009, 41, 854-868.
140. Hauser, T.A.; Hepler, C.D.; Kombo, D.C.; Grinevich, V.P.; Kiser, M.N.; Hooker, D.N.; Zhang, J.; Mountfort, D.; Selwood, A.; Akireddy, S.R.; et al. Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine. Neuropharmacology 2012, 62, 2239-2250.
141. Bourne, Y.; Radic, Z; Aráoz, R.; Talley, T.T.; Benoit, E.; Servent, D.; Taylor, P.; Molgó, J.; Marchot, P. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Proc. Natl. Acad. Sci. USA 2010, 107, 6076-6081.
142. Hogg, R.C.; Miranda, L.P.; Craik, D.J.; Lewis, R.J.; Alewood, P.F.; Adams, D.J. Single amino acid substitutions in α-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor. J. Biol. Chem. 1999, 274, 36559-36564.
143. Munday, R.; Quilliam, M.A.; LeBlanc, P.; Lewis, N.; Gallant, P.; Sperker, S.A.; Ewart, H.S.; MacKinnon, S.L. Investigations into the toxicology of spirolides, a group of marine phycotoxins. Toxins 2012, 4, 1-14.
144. Kew, J.C.; Kemp, J. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 2005, 179, 4-29. (Pubitemid 40576690)
145. Aiello, A.; D'Esposito, M.; Fattorusso, E.; Menna, M.; Müller, W.E.G.; Perović-Ottstadt, S.; Schröder, H.C. Novel bioactive bromopyrrole alkaloids from the mediterranean sponge Axinella verrucosa. Bioorg. Med. Chem. 2006, 14, 17-24.
146. Sanders, J.M.; Ito, K.; Settimo, L.; Pentikäinen, O.T.; Shoji, M.; Sasaki, M.; Johnson, M.S.; Sakai, R.; Swanson, G.T. Divergent pharmacological activity of novel marine-derived excitatory amino acids on glutamate receptors. J. Pharmacol. Exp. Ther. 2005, 314, 1068-1078.
147. Pinheiro, P.S.; Mulle, C. Presynaptic glutamate receptors: Physiological functions and mechanisms of action. Nat. Rev. Neurosci. 2008, 9, 423-436.
148. Fan, M.M.Y.; Raymond, L.A. N-Methyl-D-aspartate (NMDA) receptor function
149. Schröder, H.-C.; Sudek, S.; Caro, S.; Rosa, S.; Perovic, S.; Steffen, R.; Müller, I.M.; Müller, W.E.G. Synthesis of the neurotoxin quinolinic acid in apoptotic tissue from Suberites domuncula: Cell biological, molecular biological, and chemical analyses. Mar. Biotechnol. 2002, 4, 546-558.
150. Hampson, D.R.; Manalo, J.L. The activation of glutamate receptors by kainic acid and domoic acid. Nat. Toxins 1998, 6, 153-158. (Pubitemid 29121552)
151. Doucette, T.A.; Strain, S.M.; Allen, G.V.; Ryan, C.L.; Tasker, R.A. Comparative behavioural toxicity of domoic acid and kainic acid in neonatal rats. Neurotoxicol. Teratol. 2000, 22, 863-869.
152. Aiello, A.; D'Esposito, M.; Fattorusso, E.; Menna, M.; Müller, W.E.G.; Perović-Ottstadt, S.; Tsuruta, H.; Gulder, T.A.M.; Bringmann, G. Daminin, a bioactive pyrrole alkaloid from the mediterranean sponge Axinella damicornis. Tetrahedron 2005, 61, 7266-7270.
153. Jimenez, E.C.; Donevan, S.; Walker, C.; Zhou, L.-M.; Nielsen, J.; Cruz, L.J.; Armstrong, H.; White, H.S.; Olivera, B.M. Conantokin-L, a new NMDA receptor antagonist: Determinants for anticonvulsant potency. Epilepsy Res. 2002, 51, 73-80. (Pubitemid 35283879)
154. Blandl, T.; Warder, S.E.; Prorok, M.; Castellino, F.J. Structure-function relationships of the NMDA receptor antagonist peptide, conantokin-R. FEBS Lett. 2000, 470, 139-146. (Pubitemid 30151085)
155. Williams, A.J.; Ling, G.; McCabe, R.T.; Tortella, F.C. Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia. Neuroreport 2002, 13, 821-824. (Pubitemid 34492908)
156. Hu, J.F.; Schetz, J.A.; Kelly, M.; Peng, J.N.; Ang, K.K.; Flotow, H.; Leong, C.Y.; Ng, S.B.; Buss, A.D.; Wilkins, S.P.; et al. New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J. Nat. Prod. 2002, 65, 476-80.
157. Hedner, E.; Sjögren, M.; Frändberg, P.A.; Johansson, T.; Göransson, U.; Dahlström, M.; Jonsson, P.; Nyberg, F.; Bohlin, L. Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands. J. Nat. Prod. 2006, 69, 1421-1424.
158. Aiello, A.; Fattorusso, E.; Giordano, A.; Menna, M.; Müller, W.E.; Perović-Ottstadt, S.; Schröder, H.C. Damipipecolin and damituricin, novel bioactive bromopyrrole alkaloids from the mediterranean sponge Axinella damicornis. Bioorg. Med. Chem. 2007, 15, 5877-5887.
159. Esbenshade, T.A.; Browman, K.E.; Bitner, R.S.; Strakhova, M.; Cowart, M.D.; Brioni, J.D. The histamine H 3 receptor: an attractive target for the treatment of cognitive disorders. Br. J. Pharmacol. 2008, 154, 1166-1681.
160. Swanson, D.M.; Wilson, S.J.; Boggs, J.D.; Xiao, W.; Apodaca, R.; Barbier, A.J.; Lovenberg, T.W.; Carruthers, N.I. Aplysamine-1 and related analogs as histamine H3 receptor antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 897-900. (Pubitemid 43059847)
161. Li, P.; Reichert, D.E.; Rodríguez, A.D.; Manion, B.D.; Evers, A.S.; Eterović, V.A.; Steinbach, J.H.; Akk, G. Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate. Br. J. Pharmacol. 2008, 153, 598-608.
162. Treiman, D.M. GABAergic mechanisms in epilepsy. Epilepsia 2001, 42, 8-12. (Pubitemid 32781374)
163. Balansa, W.; Islam, R.; Gilbert, D.F.; Fontaine, F.; Xiao, X.; Zhang, H.; Piggott, A.M.; Lynch, J.W.; Capon, R.J. Australian marine sponge alkaloids as a new class of glycine-gated chloride channel receptor modulator. Bioorg. Med. Chem. 2013, 21, 4420-4425.
164. Balansa, W.; Islam, R.; Fontaine, F.; Piggott, A.M.; Zhang, H.; Webb, T.I.; Gilbert, D.F.; Lynch, J.W.; Capon, R.J. Ircinialactams: Subunit-selective glycine receptor modulators from Australian sponges of the family Irciniidae. Bioorg. Med. Chem. 2010, 18, 2912-2919.
165. Balansa, W.; Islam, R.; Fontaine, F.; Piggott, A.M.; Zhang, H.; Xiao, X.; Webb, T.I.; Gilbert, D.F.; Lynch, J.W.; Capon, R.J. Sesterterpene glycinyl-lactams: A new class of glycine receptor modulator from Australian marine sponges of the genus Psammocinia. Org. Biomol. Chem. 2013, 11, 4695-4701.
166. Sharpe, I.A.; Palant, E.; Schroeder, C.I.; Kaye, D.M.; Adams, D.J.; Alewood, P.F.; Lewis, R.J. Inhibition of the norepinephrine transporter by the venom peptide χ-MrIA: Site of action, Na+ dependence, and structure-activity relationship. J. Biol. Chem. 2003, 278, 40317-40323. (Pubitemid 37248599)
167. Sharpe, I.A.; Gehrmann, J.; Loughnan, M.L.; Thomas, L.; Adams, D.A.; Atkins, A.; Palant, E.; Craik, D.; Adams, D.J.; Alewood, P.F.; et al. Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter. Nat. Neurosci. 2001, 4, 902-907.
168. Morabito, R.; Condello, S.; Currò, M.; Marino, A.; Ientile, R.; La Spada, G. Oxidative stress induced by crude venom from the jellyfish Pelagia noctiluca in neuronal-like differentiated SH-SY5Y cells. Toxicol. In Vitro 2012, 26, 694-699.
169. Sondag, C.; Dhawan, G.; Combs, C. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J. Neuroinflammation 2009, 6, 1.
170. Liang, L.-F.; Wang, X.-J.; Zhang, H.-Y.; Liu, H.-L.; Li, J.; Lan, L.-F.; Zhang, W.; Guo, Y.-W. Bioactive polyhydroxylated steroids from the Hainan soft coral Sinularia depressa Tixier-Durivault. Bioorg. Med. Chem. Lett. 2013, 23, 1334-1337.
171. Bernstein, A.; Garrison, S.; Zambetti, G.; O'Malley, K. 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol. Neurodegener. 2011, 6, 2.
172. Ikeda, Y.; Tsuji, S.; Satoh, A.; Ishikura, M.; Shirasawa, T.; Shimizu, T. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J. Neurochem. 2008, 107, 1730-1740.
173. Perumal, A.S.; Gopal, V.B.; Tordzro, W.K.; Cooper, T.B.; Cadet, J.L. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res. Bull. 1992, 29, 699-701.
174. Sriraksa, N.; Wattanathorn, J.; Muchimapura, S.; Tiamkao, S.; Brown, K.; Chaisiwamongkol, K. Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine. Evid. Based Complement. Alternat. Med. 2012, 2012, 823206.
175. Tobón-Velasco, J.C.; Limón-Pacheco, J.H.; Orozco-Ibarra, M.; Macías-Silva, M.; Vázquez-Victorio, G.; Cuevas, E.; Ali, S.F.; Cuadrado, A.; Pedraza-Chaverrí, J.; Santamaría, A. 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors. Toxicology 2013, 304, 109-119.
176. Chen, W.-F.; Chakraborty, C.; Sung, C.-S.; Feng, C.-W.; Jean, Y.-H.; Lin, Y.-Y.; Hung, H.-C.; Huang, T.-Y.; Huang, S.-Y.; Su, T.-M.; et al. Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson's model: A promising candidate for the treatment of Parkinson's disease. Naunyn-Schmiedeberg's Arch. Pharmacol. 2012, 385, 265-275.
177. Yung, H.W.; Charnock-Jones, D.S.; Burton, G.J. Regulation of AKT phosphorylation at Ser473 and Thr308 by endoplasmic reticulum stress modulates substrate specificity in a severity dependent manner. PLoS One 2011, 6, e17894.
178. Dai, R.; Xia, Y.; Mao, L.; Mei, Y.; Xue, Y.; Hu, B. Involvement of PI3K/Akt pathway in the neuroprotective effect of sonic hedgehog on cortical neurons under oxidative stress. J. Huazhong Univ. Sci. Technol. Med. Sci. 2012, 32, 856-860.
179. Hayden, M.S.; Ghosh, S. Signaling to NF-κB. Genes Dev. 2004, 18, 2195-2224.
180. Flood, P.M.; Qian, L.; Peterson, L.J.; Zhang, F.; Shi, J.-S.; Gao, H.-M.; Hong, J.-S. Transcriptional factor NF-κB as a target for therapy in Parkinson's disease. Parkinsons Dis. 2011, 2011, doi:10.4061/2011/216298.
181. Chen, B.-W.; Chao, C.-H.; Su, J.-H.; Huang, C.-Y.; Dai, C.-F.; Wen, Z.-H.; Sheu, J.-H. A novel symmetric sulfur-containing biscembranoid from the Formosan soft coral Sinularia flexibilis. Tetrahedron Lett. 2010, 51, 5764-5766.
182. Ye, Q.; Zhang, X.; Huang, B.; Zhu, Y.; Chen, X. Astaxanthin suppresses MPP+-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar. Drugs 2013, 11, 1019-1034.
183. Jean, Y.-H.; Chen, W.-F.; Sung, C.-S.; Duh, C.-Y.; Huang, S.-Y.; Lin, C.-S.; Tai, M.-H.; Tzeng, S.-F.; Wen, Z.-H. Capnellene, a natural marine compound derived from soft coral, attenuates chronic constriction injury-induced neuropathic pain in rats. Br. J. Pharmacol. 2009, 158, 713-725.
184. Mayer, A.M.S.; Avilés, E.; Rodríguez, A.D. Marine sponge Hymeniacidon sp. amphilectane metabolites potently inhibit rat brain microglia thromboxane B2 generation. Bioorg. Med. Chem. 2012, 20, 279-282.
185. Ceulemans, A.-G.; Zgavc, T.; Kooijman, R.; Hachimi-Idrissi, S.; Sarre, S.; Michotte, Y. The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia. J. Neuroinflammation 2010, 7, 74.
186. Bitzer-Quintero, O.K.; González-Burgos, I. Immune system in the brain: A modulatory role on dendritic spine morphophysiology? Neural Plast. 2012, 2012, ID 348642.
187. Aïd, S.; Bosetti, F. Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications. Biochimie 2011, 93, 46-51.
188. Cacquevel, M.; Lebeurrier, N.; Cheenne, S.; Vivien, D. Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 2004, 5, 529-534. (Pubitemid 39004427)
189. Mennicken, F.; Maki, R.; de Souza, E.B.; Quirion, R. Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 1999, 20, 73-78. (Pubitemid 29322314)
190. Ryan, J.C.; Cross, C.A.; Van Dolah, F.M. Effects of COX inhibitors on neurodegeneration and survival in mice exposed to the marine neurotoxin domoic acid. Neurosci. Lett. 2011, 487, 83-87.
191. Tapiolas, D.M.; Bowden, B.F.; Abou-Mansour, E.; Willis, R.H.; Doyle, J.R.; Muirhead, A.N.; Liptrot, C.; Llewellyn, L.E.; Wolff, C.W.W.; Wright, A.D.; et al. Eusynstyelamides A, B, and C, nNOS Inhibitors, from the ascidian Eusynstyela latericius. J. Nat. Prod. 2009, 72, 1115-1120.
192. Huang, S.-Y.; Chen, N.-F.; Chen, W.-F.; Hung, H.-C.; Lee, H.-P.; Lin, Y.-Y.; Wang, H.-M.; Sung, P.-J.; Sheu, J.-H.; Wen, Z.-H. Sinularin from indigenous soft coral attenuates nociceptive responses and spinal neuroinflammation in carrageenan-induced inflammatory rat model. Mar. Drugs 2012, 10, 1899-1919.
193. Tseng, Y.-J.; Wen, Z.-H.; Dai, C.-F.; Chiang, M.Y.; Sheu, J.-H. Nanolobatolide, a new C18 metabolite from the Formosan soft coral Sinularia nanolobata. Org. Lett. 2009, 11, 5030-5032.
194. Rodríguez, I.I.; Shi, Y.-P.; García, O.J.; Rodríguez, A.D.; Mayer, A.M.S.; Sánchez, J.A.; Ortega-Barria, E.; González, J. New pseudopterosin and seco-pseudopterosin diterpene glycosides from two Colombian isolates of Pseudopterogorgia elisabethae and their diverse biological activities. J. Nat. Prod. 2004, 67, 1672-1680.
195. Shi, Y.-P.; Wei, X.; Rodríguez, I.I.; Rodríguez, A.D.; Mayer, A.M.S. New terpenoid constituents of the southwestern Caribbean sea whip Pseudopterogorgia elisabethae (Bayer), including a unique pentanorditerpene. Eur. J. Org. Chem. 2009, 2009, 493-502.
196. Vago, R. Beyond the skeleton: Cnidarian biomaterials as bioactive extracellular microenvironments for tissue engineering. Organogenesis 2008, 4, 18-22. (Pubitemid 351754417)
197. LaPlaca, M.C.; Vernekar, V.N.; Shoemaker, J.T.; Cullen, D.K. Methods in Bioengineering: 3D Tissue Engineering; Berthiaume, F.; Morgan, J.R., Eds.; Artech House Publishers: Norwood, MA, USA, 2010; pp. 187-204.
198. Shanny, B.; Vago, R.; Baranes, D. Growth of primary hippocampal neuronal tissue on an aragonite crystalline biomatrix. Tissue Eng. 2005, 11, 585-596. (Pubitemid 40632573)
199. Peretz, H.; Blinder, P.; Segal, L.; Baranes, D.; Vago, R. Aragonite crystalline matrix as an instructive microenvironment for neural development. J. Tissue Eng. Regen. Med. 2008, 2, 463-471.
200. Gautier, S.E.; Oudega, M.; Fragoso, M.; Chapon, P.; Plant, G.W.; Bunge, M.B.; Parel, J.-M. Poly(α-hydroxyacids) for application in the spinal cord: Resorbability and biocompatibility with adult rat Schwann cells and spinal cord. J. Biomed. Mater. Res. 1998, 42, 642-654. (Pubitemid 28503771)
201. Tibbitt, M.W.; Anseth, K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol. Bioeng. 2009, 103, 655-663.
202. Peretz, H.; Talpalar, A.E.; Vago, R.; Baranes, D. Superior survival and durability of neurons and astrocytes on 3-dimensional aragonite biomatrices. Tissue Eng. 2007, 13, 461-472. (Pubitemid 46579873)
203. Seibold, E.; Berger, W.H. The Sea Floor: An Introduction to Marine Geology; Springer: Heidelberg, Germany, 1996.
204. Burgess, J.G. New and emerging analytical techniques for marine biotechnology. Curr. Opin. Biotechnol. 2012, 23, 29-33
205. Liu, Y. Renaissance of marine natural product drug discovery and development. J. Mar. Sci. Res. Dev. 2012, 2, 2.
206. Montaser, R.; Luesch, H. Marine natural products: A new wave of drugs? Future Med. Chem. 2011, 3, 1475-1489.
207. Murakami, N.; Nakajima, T.; Kobayashi, M. Total synthesis of lembehyne A, a neuritogenic spongean polyacetylene. Tetrahedron Lett. 2001, 42, 1941-1943. (Pubitemid 32179574)
208. Boger, D.L.; Boyce, C.W.; Labroli, M.A.; Sehon, C.A.; Jin, Q. Total syntheses of ningalin A, lamellarin O, lukianol A, and permethyl storniamide A utilizing heterocyclic azadiene Diels-Alder reactions. J. Am. Chem. Soc. 1998, 121, 54-62. (Pubitemid 29047122)
209. Xu, Y.-z.; Yakushijin, K.; Horne, D.A. Synthesis of C11N5 marine sponge alkaloids: (±)-Hymenin, stevensine, hymenialdisine, and debromohymenialdisine. J. Org. Chem. 1997, 62, 456-464.
210. Tepe, J. Preparation of hymenialdisine derivatives and use thereof. U.S. Patent 7,732,436, 8 June 2010.
211. Wan, Y.; Hur, W.; Cho, C.Y.; Liu, Y.; Adrian, F.J.; Lozach, O.; Bach, S.; Mayer, T.; Fabbro, D.; Meijer, L.; et al. Synthesis and target identification of hymenialdisine analogs. Chem. Biol. 2004, 11, 247-259.
212. Nguyen, T.N.; Tepe, J.J. Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors. Curr. Med. Chem. 2009, 16, 3122-3143.
213. Ishibashi, F.; Miyazaki, Y.; Iwao, M. Total syntheses of lamellarin D and H. The first synthesis of lamellarin-class marine alkaloids. Tetrahedron 1997, 53, 5951-5962. (Pubitemid 27174349)
214. Pla, D.; Marchal, A.; Olsen, C.A.; Albericio, F.; Álvarez, M. Modular total synthesis of lamellarin D. J. Org. Chem. 2005, 70, 8231-8234.
215. Fujikawa, N.; Ohta, T.; Yamaguchi, T.; Fukuda, T.; Ishibashi, F.; Iwao, M. Total synthesis of lamellarins D, L, and N. Tetrahedron 2006, 62, 594-604. (Pubitemid 41779378)
216. Pla, D.; Marchal, A.; Olsen, C.A.; Francesch, A.; Cuevas, C.; Albericio, F.; Álvarez, M. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid lamellarin D. J. Med. Chem. 2006, 49, 3257-3268.
217. Cironi, P.; Manzanares, I.; Albericio, F.; Álvarez, M. Solid-phase total synthesis of the pentacyclic system lamellarins U and L. Org. Lett. 2003, 5, 2959-2962.
218. Roué, N.; Bergman, J. Synthesis of the marine alkaloid leucettamine B. Tetrahedron 1999, 55, 14729-14738.
219. Toma, T.; Kita, Y.; Fukuyama, T. Total synthesis of (+)-manzamine A. J. Am. Chem. Soc. 2010, 132, 10233-10235.
220. Jakubec, P.; Hawkins, A.; Felzmann, W.; Dixon, D.J. Total synthesis of manzamine A and related alkaloids. J. Am. Chem. Soc. 2012, 134, 17482-17485.
221. Perez, M.; Perez, D.I.; Martinez, A.; Castro, A.; Gomez, G.; Fall, Y. The first enantioselective synthesis of palinurin. Chem. Commun. 2009, 2009, 3252-3254.
222. Zhidkov, M.E.; Baranova, O.V.; Kravchenko, N.S.; Dubovitskii, S.V. A new method for the synthesis of the marine alkaloid fascaplysin. Tetrahedron Lett. 2010, 51, 6498-6499.
223. Bharate, S.B.; Manda, S.; Joshi, P.; Singh, B.; Vishwakarma, R.A. Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin. Med. Chem. Commun. 2012, 3, 1098-1103.
224. Dai, Q.; Liu, F.; Zhou, Y.; Lu, B.; Yu, F.; Huang, P. The synthesis of SO-3, a conopeptide with high analgesic activity derived from Conus striatus. J. Nat. Prod. 2003, 66, 1276-1279. (Pubitemid 37204239)
225. Sobarzo-Sánchez, E.; Castedo, L.; De la Fuente, J.R. Synthesis of anabaseine and anabasine derivatives: Structural modifications of possible nicotinic agonists. Synth. Commun. 2007, 37, 1331-1338.
226. Toyooka, N.; Yotsui, Y.; Yoshida, Y.; Momose, T.; Nemoto, H. Highly stereoselective construction of 4,6- cis-substituted quinolizidine ring core: an application to enantioselective total synthesis of the marine alkaloid clavepictines A, B and pictamine. Tetrahedron 1999, 55, 15209-15224.
227. Yu, S.; Pu, X.; Cheng, T.; Wang, R.; Ma, D. Total synthesis of clavepictines A and B and pictamine. Org. Lett. 2006, 8, 3179-3182. (Pubitemid 44187410)
228. Toyooka, N.; Okumura, M.; Takahata, H.; Nemoto, H. Construction of 4a,8a-cis-octahydroquinolin-7-one core using an intramolecular aldol type of cyclization: An application to enantioselective total synthesis of lepadin B. Tetrahedron 1999, 55, 10673-10684. (Pubitemid 29389903)
229. Ozawa, T.; Aoyagi, S.; Kibayashi, C. Total synthesis of the marine alkaloid (-)-lepadin B. Org. Lett. 2000, 2, 2955-2958.
230. Barbe, G.; Charette, A.B. Total synthesis of (+)-lepadin B: Stereoselective synthesis of nonracemic polysubstituted hydroquinolines using an RC-ROM Process. J. Am. Chem. Soc. 2008, 130, 13873-13875.
231. McIntosh, J.M.; Yoshikami, D.; Mahe, E.; Nielsen, D.B.; Rivier, J.E.; Gray, W.R.; Olivera, B.M. A nicotinic acetylcholine receptor ligand of unique specificity, alpha-conotoxin ImI. J. Biol.Chem. 1994, 269, 16733-16739.
232. Stivala, C.E.; Gu, Z.; Smith, L.L.; Zakarian, A. Studies toward the synthesis of spirolide C: Exploration into the formation of the 23-membered all-carbon macrocyclic framework. Org. Lett. 2012, 14, 804-807.
233. Kong, K.; Romo, D.; Lee, C. Enantioselective total synthesis of the marine toxin (-)-gymnodimine employing a barbier-type macrocyclization. 2011, 121, 7538-7541.
234. Sakai, R.; Koike, T.; Sasaki, M.; Shimamoto, K.; Oiwa, C.; Yano, A.; Suzuki, K.; Tachibana, K.; Kamiya, H. Isolation, structure determination and synthesis of neodysiherbaine A, a new excitatory amino acid from a marine sponge. Org. Lett. 2001, 3, 1479-1482. (Pubitemid 33631614)
235. Lygo, B.; Slack, D.; Wilson, C. Synthesis of neodysiherbaine. Tetrahedron Lett. 2005, 46, 6629-6632. (Pubitemid 41207138)
236. Takahashi, K.; Matsumura, T.; Corbin, G.R.; Ishihara, J.; Hatakeyama, S. A highly stereocontrolled total synthesis of (-)-neodysiherbaine A. J. Org. Chem. 2006, 71, 4227-4231. (Pubitemid 43794629)
237. Donohoe, T.J.; Winship, P.C.M.; Tatton, M.R.; Szeto, P. A short and efficient synthesis of neodysiherbaine A by using catalytic oxidative cyclization. Angew. Chem. Int. Ed. 2011, 50, 7604-7606.
238. Takita, S.; Yokoshima, S.; Fukuyama, T. A practical synthesis of (-)-kainic Acid. Org. Lett. 2011, 13, 2068-2070.
239. Orellana, A.; Pandey, S.K.; Carret, S.; Greene, A.E.; Poisson, J.-F. A Diels-Alder-based total synthesis of (-)-kainic acid. J. Org. Chem. 2012, 77, 5286-5296.
240. Stathakis, C.I.; Yioti, E.G.; Gallos, J.K. Total syntheses of (-)-α-kainic Acid. Eur. J. Org. Chem. 2012, 2012, 4661-4673.
241. Kesava Reddy, N.; Chandrasekhar, S. Total synthesis of (-)-α-kainic acid via chirality transfer through Ireland-Claisen rearrangement. J. Org. Chem. 2013, 78, 3355-3360.
242. Ohfune, Y.; Tomita, M., Total synthesis of (-)-domoic acid. A revision of the original structure. J. Am. Chem. Soc. 1982, 104, 3511-3513. (Pubitemid 12027713)
243. Rivier, J.; Galyean, R.; Simon, L.; Cruz, L.J.; Olivera, B.M.; Gray, W.R. Total synthesis and further characterization of the γ-carboxyglutamate- containing "sleeper" peptide from Conus geographus venom. Biochemistry 1987, 26, 8508-8512.
244. Nakamura, M.; Suzuki, A.; Nakatani, M.; Fuchikami, T.; Inoue, M.; Katoh, T. An efficient synthesis of (+)-aureol via boron trifluoride etherate-promoted rearrangement of (+)-arenarol. Tetrahedron Lett. 2002, 43, 6929-6932. (Pubitemid 35246082)
245. Nakatani, M.; Nakamura, M.; Suzuki, A.; Fuchikami, T.; Inoue, M.; Katoh, T. Enantioselective total synthesis of (+)-aureol via a BF3·Et 2O-promoted rearrangement/cyclization reaction of (+)-arenarol. Arch. Org. Chem. 2003, 8, 45-57.
246. Kuan, K.K.W.; Pepper, H.P.; Bloch, W.M.; George, J.H. Total synthesis of (+)-aureol. Org. Lett. 2012, 14, 4710-4713.
247. Brandt, S.D.; Moore, S.A.; Freeman, S.; Kanu, A.B. Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry. Drug Test. Anal. 2010, 2, 330-338.
248. Johnson, A.-L.; Bergman, J.; Sjögren, M.; Bohlin, L. Synthesis of barettin. Tetrahedron 2004, 60, 961-965.
249. Aiello, A.; Giordano, A.; Fattorusso, E.; Menna, M.; Schroeder, H.C.; Mueller, W.E.G. Isolation, Structure Determination, Synthesis and Bioactivity of Damipipecolin and Damituricin. EP Patent 2007107319 A1, 27 September 2007.
250. Yoshida, M.; Yamaguchi, K. Total synthesis of dispyrin, purpurealidin E, and aplysamine-1. Chem. Pharm. Bull. 2008, 56, 1362-1363.
251. Gulati, D.; Chauhan, P.M.S.; Pratap, R.; Bhakuni, D.S. A new synthesis of aplysinopsin, a marine alkaloid and its analogues and their biological antivities. Indian J. Chem. 1994, 33B, 4-9.
252. Leftwick, A.P.; Weedon, B.C.L. Total synthesis of astaxanthin and hydroxyechinenone. Chem. Commun. (Lond.) 1967, 49-50.
253. Cheng, H.M.; Tian, W.; Peixoto, P.A.; Dhudshia, B.; Chen, D.Y.K. Synthesis of ent-nanolobatolide. Angew. Chem. Int. Ed. 2011, 50, 4165-4168.
254. Ladlow, M.; Pattenden, G.; Teague, S.J. Synthesis of Δ9(12)- capnellene-8β,10α-diol from soft coral Capnella imbricata. Tetrahedron Lett. 1986, 27, 3279-3280.
255. Pattenden, G.; Teague, S.J. Total synthesis of (±)-Δ9(12)- capnellene-8β,10α-diol. J. Chem. Soc. Perkin Trans. 1 1988, 1988, 1077-1083.
256. Piers, E.; Llinas-Brunet, M. Total synthesis of (±)-8,15- diisocyano-11(20)-amphilectene. J. Org. Chem. 1989, 54, 1483-1484.
257. Avilés, E.; Rodríguez, A.D. Monamphilectine A, a potent antimalarial β-lactam from marine sponge Hymeniacidon sp: Isolation, structure, semisynthesis, and Bioactivity. Org. Lett. 2010, 12, 5290-5293.
258. Broka, C.A.; Chan, S.; Peterson, B. Total synthesis of (-)-pseudopterosin A. J. Org. Chem. 1988, 53, 1584-1586.
259. Buszek, K.R.; Bixby, D.L. Total synthesis of pseudopterosin A and E aglycon. Tetrahedron Lett. 1995, 36, 9129-9132.
260. Kocienski, P.J.; Pontiroli, A.; Qun, L. Enantiospecific syntheses of pseudopterosin aglycones. Part 2. Synthesis of pseudopterosin K-L aglycone and pseudopterosin A-F aglycone via a B→BA→BAC annulation strategy. J. Chem. Soc. Perkin Trans. 1 2001, 2001, 2356-2366.
261. Harrowven, D.C.; Tyte, M.J. Total synthesis of (±)-pseudopterosin A-F and K-L aglycone. Tetrahedron Lett. 2004, 45, 2089-2091. (Pubitemid 38229297)
262. Barykina, O.V.; Snider, B.B. Synthesis of (±)-eusynstyelamide A. Org. Lett. 2010, 12, 2664-2667.